Incidence and Risk Factors of Post-Induction Hypotension in Geriatric Cancer Patients
A Prospective Observational Study to Determine the Incidence and Risk Factors of Post-Induction Hypotension in Geriatric Oncologic Patients Undergoing General Anesthesia at a Tertiary Oncology Center
1 other identifier
observational
140
1 country
1
Brief Summary
This observational clinical study aims to investigate the incidence and risk factors of post-induction hypotension (PIH) in geriatric cancer patients undergoing surgery under general anesthesia. PIH is defined as a drop in mean arterial pressure of ≥30% from baseline or below 65 mmHg within the first 20 minutes after anesthesia induction, prior to surgical stimulation. The primary objective is to determine the frequency of PIH in elderly oncology patients. Secondary objectives include evaluating the association of PIH with age, ASA score, cancer type, oncological treatments (chemotherapy/radiotherapy), comorbidities, medication use, anemia, biochemical parameters, and preoperative perfusion index (PI) and pleth variability index (PVI). Findings from this study are expected to contribute to improved perioperative management and to the development of tailored anesthesia protocols for geriatric oncology patients.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started May 2025
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
May 25, 2025
CompletedFirst Submitted
Initial submission to the registry
December 7, 2025
CompletedFirst Posted
Study publicly available on registry
December 19, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 25, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
May 25, 2026
December 19, 2025
May 1, 2025
1 year
December 7, 2025
December 7, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Incidence of Post-Induction Hypotension (PIH) in Geriatric Oncologic Patients
PIH defined as ≥30% decrease from pre-induction MAP or MAP \< 65 mmHg at any measurement within the window (NIBP every 2 minutes). Outcome reported as the proportion of participants meeting PIH criteria.
From anesthesia induction to 15 minutes after intubation (≈ first 20 minutes post-induction)
Secondary Outcomes (1)
Association of Demographic, Oncologic, and Anesthetic Factors With Post-Induction Hypotension
From preoperative assessment to 20 minutes after anesthesia induction
Study Arms (1)
Geriatric Oncologic Patients Monitored for Post-Induction Blood Pressure
This cohort includes geriatric patients (≥65 years) with a confirmed cancer diagnosis who are scheduled for surgery under general anesthesia. The focus of the study is on monitoring and evaluating post-induction blood pressure changes. Standard non-invasive monitoring (ECG, NIBP, SpO₂) will be applied, and blood pressure will be measured at predefined intervals in the first 20 minutes following anesthesia induction. The study aims to assess the frequency and determinants of post-induction hypotension in this patient population.
Eligibility Criteria
The study population will consist of geriatric patients (≥65 years) undergoing oncologic surgery at Dr. Abdurrahman Yurtaslan Ankara Oncology Training and Research Hospital, Ankara, Turkey.
You may qualify if:
- Adults ≥65 years of age
- Patients with a diagnosis of cancer and scheduled for surgery
- Ability and willingness to provide written informed consent
- ASA physical status class II-IV
You may not qualify if:
- Patients under 65 years of age
- Patients without a confirmed oncologic diagnosis
- Refusal to provide written informed consent
- Patients undergoing regional anesthesia
- Patients with tracheostomy or requiring multiple intubation attempts
- History of peripheral arterial disease
- Use of vasopressors before the start of surgery
- Uncontrolled hypertension (blood pressure \>180/110 mmHg)
- Advanced heart failure (Ejection Fraction \<40%)
- Severe arrhythmias such as atrial fibrillation or significant ventricular arrhythmias that preclude reliable hemodynamic monitoring
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Dolunay ARIKlead
Study Sites (1)
Dr. Abdurrahman Yurtaslan Oncology Training and Research Hospital
Ankara, Ankara, 06200, Turkey (Türkiye)
Related Publications (5)
Phillips AT, Deiner S, Mo Lin H, Andreopoulos E, Silverstein J, Levin MA. Propofol Use in the Elderly Population: Prevalence of Overdose and Association With 30-Day Mortality. Clin Ther. 2015 Dec 1;37(12):2676-85. doi: 10.1016/j.clinthera.2015.10.005. Epub 2015 Nov 6.
PMID: 26548320BACKGROUNDSudfeld S, Brechnitz S, Wagner JY, Reese PC, Pinnschmidt HO, Reuter DA, Saugel B. Post-induction hypotension and early intraoperative hypotension associated with general anaesthesia. Br J Anaesth. 2017 Jul 1;119(1):57-64. doi: 10.1093/bja/aex127.
PMID: 28974066BACKGROUNDBloom MW, Hamo CE, Cardinale D, Ky B, Nohria A, Baer L, Skopicki H, Lenihan DJ, Gheorghiade M, Lyon AR, Butler J. Cancer Therapy-Related Cardiac Dysfunction and Heart Failure: Part 1: Definitions, Pathophysiology, Risk Factors, and Imaging. Circ Heart Fail. 2016 Jan;9(1):e002661. doi: 10.1161/CIRCHEARTFAILURE.115.002661.
PMID: 26747861BACKGROUNDLevin MA, Fischer GW, Lin HM, McCormick PJ, Krol M, Reich DL. Intraoperative arterial blood pressure lability is associated with improved 30 day survival. Br J Anaesth. 2015 Nov;115(5):716-26. doi: 10.1093/bja/aev293. Epub 2015 Sep 22.
PMID: 26395645BACKGROUNDAbebe MM, Arefayne NR, Temesgen MM, Admass BA. Incidence and predictive factors associated with hemodynamic instability among adult surgical patients in the post-anesthesia care unit, 2021: A prospective follow up study. Ann Med Surg (Lond). 2022 Jan 29;74:103321. doi: 10.1016/j.amsu.2022.103321. eCollection 2022 Feb.
PMID: 35145680BACKGROUND
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- Resident doctor
Study Record Dates
First Submitted
December 7, 2025
First Posted
December 19, 2025
Study Start
May 25, 2025
Primary Completion (Estimated)
May 25, 2026
Study Completion (Estimated)
May 25, 2026
Last Updated
December 19, 2025
Record last verified: 2025-05
Data Sharing
- IPD Sharing
- Will not share
No plan to share IPD publicly. Interested researchers may contact the principal investigator for data access